Published • loading... • Updated
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
Summary by Hastings Tribune
6 Articles
6 Articles
DECRYPTAGE - The pharmaceutical laboratory and the French start-up specialized in biology applied AI have signed a new five-year partnership on Friday.
·Paris, France
Read Full Article
Hastings Tribune+3 Reposted by 3 other sources
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
NEW YORK & PARIS--(BUSINESS WIRE)--Jun 5, 2026-
·Nebraska, United States
Read Full Article
Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
Agentic AI company Owkin and Sanofi have extended their collaboration with a five-year license for K Pro, Owkin’s AI scientist, under which Owkin will lead the end-to-end development of novel, purpose-built biopharma agents for Sanofi. Owkin pitches K Pro as a system that reasons over biological data and orchestrates AI agents to run research and… The post Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agent…
Coverage Details
Total News Sources6
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
